The COVID‐19 pandemic has become an urgent issue in every country. Based on recent
reports, the most severely ill patients present with coagulopathy, and disseminated …

Severe acute respiratory syndrome coronavirus 2, coronavirus disease 2019 (COVID-19)-
induced infection can be associated with a coagulopathy, findings consistent with infection …

The pathology of coronavirus disease 2019 (COVID-19) is exacerbated by the progression
of thrombosis, and disseminated intravascular coagulation (DIC), and cytokine storms. The …

Background Abnormal coagulation parameters have been reported in COVID‐19‐infected
patients. Although the underlying mechanism of COVID‐19 coagulopathy remains unknown …

Coagulopathy correlates with severity of COVID-19 and may include increased d-dimer
concentrations (≥ 2 times above normal range), mildly prolonged prothrombin time (~ 1–3 s …

Infection with the SARS-CoV-2 virus, resulting in COVID-19 disease, has presented a
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …

Thrombotic complications and coagulopathy frequently occur in COVID-19. However, the
characteristics of COVID-19-associated coagulopathy (CAC) are distinct from those seen …

Abstract Coronavirus disease 2019 (COVID-19) causes a spectrum of disease; some
patients develop a severe proinflammatory state which can be associated with a unique …

This illustrated review discusses the haemostatic changes seen in patients with severe
coronavirus disease 2019 (COVID‐19) infection and their possible causes. We discuss the …

December 2019 will never be forgotten in the history of medicine when an outbreak of
pneumonia of unknown etiology in Wuhan, China sooner or later prompted the World Health …